文献速递肝病

肝硬化肝巨噬细胞PD-L1过表达及其阻断改善抗菌功能

Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections.
PubMed 文献 · Hepatology · 2021-06-02

该研究通过转录组分析和流式细胞术表征人肝硬化肝巨噬细胞表型,并在小鼠慢性肝损伤模型中用转盘活体显微镜测量肝巨噬细胞体内吞噬活性。发现肝硬化肝巨噬细胞过表达PD-L1等免疫耗竭相关蛋白,体内吞噬活性显著受损,抗PD-L1抗体阻断可逆转免疫抑制表型并减少细菌播散。

要点

  • 肝硬化患者肝巨噬细胞过表达PD-L1、MARCO和CD163等免疫耗竭相关蛋白。
  • 肝硬化患者肝巨噬细胞体内吞噬活性显著受损,外周单核细胞PD-L1过表达与疾病严重程度平行。
  • 抗PD-L1抗体阻断可使巨噬细胞表型向免疫抑制减弱方向转变,恢复吞噬活性并减少细菌播散。

核心结论

  • 肝硬化以巨噬细胞吞噬功能显著受损为特征,并伴有免疫抑制性转录组谱。
  • 程序性细胞死亡受体1/PD-L1轴在肝巨噬细胞活性受损中起主要作用。
  • PD-L1阻断可逆转肝硬化中的免疫抑制谱并增强肝巨噬细胞的抗菌活性。

研究设计与样本

  • 人肝硬化肝巨噬细胞通过转录组分析和流式细胞术进行表型表征。
  • 肝硬化患者肝巨噬细胞体内功能通过单光子发射计算机断层扫描评估。
  • 血清特定蛋白水平和外周单核细胞表达通过ELISA和流式细胞术测定。
  • 小鼠慢性肝损伤模型中肝巨噬细胞体内吞噬活性通过转盘活体显微镜测量。

主要发现

  • 肝硬化患者肝巨噬细胞过表达PD-L1、MARCO和CD163等免疫耗竭相关蛋白。
  • 肝硬化患者肝巨噬细胞体内吞噬活性显著受损。
  • 肝硬化患者单核细胞PD-L1过表达与疾病严重程度平行,与其血清水平相关,并与感染风险增加相关。
  • 抗PD-L1抗体阻断使巨噬细胞表型向免疫抑制减弱方向转变,恢复肝巨噬细胞体内吞噬活性并减少细菌播散。

临床怎么用

  • 肝硬化患者外周单核细胞PD-L1过表达与疾病严重程度平行且与感染风险增加相关,或可作为感染风险评估的参考指标。
  • PD-L1阻断在肝硬化中可恢复肝巨噬细胞吞噬活性并增强抗菌活性,为抗感染治疗提供了潜在靶点方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Bacterial infections are common and severe in cirrhosis, but their pathogenesis is poorly understood. Dysfunction of liver macrophages may play a role, but information about their function in cirrhosis is limited. Our aims were to investigate the specific profile and function of liver macrophages in cirrhosis and their contribution to infections. Macrophages from human cirrhotic livers were characterized phenotypically by transcriptome analysis and flow cytometry; function was assessed in vivo by single photon emission computerized tomography in patients with cirrhosis. Serum levels of specific proteins and expression in peripheral monocytes were determined by ELISA and flow cytometry. In vivo phagocytic activity of liver macrophages was measured by spinning disk intravital microscopy in a mouse model of chronic liver injury. APPROACH AND RESULTS: Liver macrophages from patients with cirrhosis overexpressed proteins related to immune exhaustion, such as programmed death ligand 1 (PD-L1), macrophage receptor with collagenous structure (MARCO), and CD163. In vivo phagocytic activity of liver macrophages in patients with cirrhosis was markedly impaired. Monocytes from patients with cirrhosis showed overexpression of PD-L1 that paralleled disease severity, correlated with its serum levels, and was associated with increased risk of infections. Blockade of PD-L1 with anti-PD-L1 antibody caused a shift in macrophage phenotype toward a less immunosuppressive profile, restored liver macrophage in vivo phagocytic activity, and reduced bacterial dissemination. CONCLUSION: Liver cirrhosis is characterized by a remarkable impairment of phagocytic function of macrophages associated with an immunosuppressive transcriptome profile. The programmed cell death receptor 1/PD-L1 axis plays a major role in the impaired activity of liver macrophages. PD-L1 blockade reverses the immune suppressive profile and increases antimicrobial activity of liver macrophages in cirrhosis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Pose E, Coll M, Martínez-Sánchez C, et al. Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections. Hepatology. 2021. PMID: 33219516. doi:10.1002/hep.31644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。